#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3624874	P	Solubility of the compound in 1:1 mixture of phosphate buffer and EtOH		2	ALA3621165	small-molecule physicochemical format	Scientific Literature
2.	ALA3624875	A	Clearance in ICR mouse plasma at 1 mg/kg, iv	Mus musculus	2	ALA3621165	organism-based format	Scientific Literature
3.	ALA3624876	A	Elimination half-life in ICR mouse plasma at 1 mg/kg, iv	Mus musculus	2	ALA3621165	organism-based format	Scientific Literature
4.	ALA3624877	A	Volume of distribution at steady state in ICR mouse at 1 mg/kg, iv	Mus musculus	2	ALA3621165	organism-based format	Scientific Literature
5.	ALA3624878	A	AUC (0 to infinity) in ICR mouse at 1 mg/kg, iv	Mus musculus	2	ALA3621165	organism-based format	Scientific Literature
6.	ALA3624879	A	Cmax in ICR mouse plasma at 10 mg/kg, po	Mus musculus	2	ALA3621165	organism-based format	Scientific Literature
7.	ALA3624880	A	Elimination half-life in ICR mouse plasma at 10 mg/kg, po	Mus musculus	2	ALA3621165	organism-based format	Scientific Literature
8.	ALA3624881	A	Oral bioavailability in ICR mouse at 10 mg/kg	Mus musculus	2	ALA3621165	organism-based format	Scientific Literature
9.	ALA3624882	A	AUC (0 to infinity) in ICR mouse at 10 mg/kg, po	Mus musculus	2	ALA3621165	organism-based format	Scientific Literature
10.	ALA3624883	F	Antitumor activity against human Caki1 cells xenografted in BALB/c nu mouse assessed as tumor growth inhibition at 1 mg/kg, po administered 5 times a week for 4 weeks measured after 42 days relative to control	Homo sapiens	1	ALA3621165	organism-based format	Scientific Literature
11.	ALA3624884	F	Antitumor activity against human Caki1 cells xenografted in BALB/c nu mouse assessed as tumor growth inhibition at 3 mg/kg, po administered 5 times a week for 4 weeks measured after 42 days relative to control	Homo sapiens	1	ALA3621165	organism-based format	Scientific Literature
12.	ALA3624885	F	Cell cycle arrest in human Caki1 cells assessed as accumulation at sub-G1 phase at 1000 pM after 24 hrs by flow cytometry (Rvb = 0.8%)	Homo sapiens	2	ALA3621165	cell-based format	Scientific Literature
13.	ALA3624886	T	Toxicity in human Caki1 cells xenografted BALB/c nu mouse assessed as body weight change at 1 mg/kg, po administered 5 times a week for 4 weeks measured every 2 to 3 days	Mus musculus	1	ALA3621165	organism-based format	Scientific Literature
14.	ALA3624887	T	Toxicity in human Caki1 cells xenografted BALB/c nu mouse assessed as body weight change at 3 mg/kg, po administered 5 times a week for 4 weeks measured every 2 to 3 days	Mus musculus	1	ALA3621165	organism-based format	Scientific Literature
15.	ALA3624888	A	Overt toxicity in human Caki1 cells xenografted BALB/c nu mouse at 1 mg/kg, po administered 5 times a week for 4 weeks	Mus musculus	1	ALA3621165	organism-based format	Scientific Literature
16.	ALA3625007	A	Overt toxicity in human Caki1 cells xenografted BALB/c nu mouse at 3 mg/kg, po administered 5 times a week for 4 weeks	Mus musculus	1	ALA3621165	organism-based format	Scientific Literature
17.	ALA3625008	F	Antitumor activity against human Caki1 cells xenografted BALB/c-nu mouse assessed as down regulation of PCNA in tumor tissue at 1 to 3 mg/kg, po administered 5 times a week for 4 weeks by Western blot analysis	Homo sapiens	1	ALA3621165	organism-based format	Scientific Literature
18.	ALA3625009	F	Antitumor activity against human Caki1 cells xenografted BALB/c-nu mouse assessed as down regulation of NNMT in tumor tissue at 1 to 3 mg/kg, po administered 5 times a week for 4 weeks by Western blot analysis	Homo sapiens	1	ALA3621165	organism-based format	Scientific Literature
19.	ALA3625010	F	Antitumor activity against human Caki1 cells xenografted BALB/c-nu mouse assessed as up-regulation of phosphorylated JNK in tumor tissue at 1 to 3 mg/kg, po administered 5 times a week for 4 weeks by Western blot analysis	Homo sapiens	1	ALA3621165	organism-based format	Scientific Literature
20.	ALA3625011	F	Antitumor activity against human Caki1 cells xenografted BALB/c-nu mouse assessed as down-regulation of phosphorylated p38 in tumor tissue at 1 to 3 mg/kg, po administered 5 times a week for 4 weeks by Western blot analysis	Homo sapiens	1	ALA3621165	organism-based format	Scientific Literature